Cargando…

Acromegaly disease activity according to ACRODAT®, a cross-sectional study in Spain: ACROVAL study

OBJECTIVES: To evaluate disease activity status using the Acromegaly Disease Activity Tool (ACRODAT(®)) in a cohort of Spanish acromegaly patients, to assess the relationship between the level of disease activity according to both ACRODAT(®) and the physicians’ clinical evaluation, and to study the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marazuela, Mónica, Blanco, Concepción, Bernabeu, Ignacio, Menendez, Edelmiro, Villar, Rocío, Paja, Miguel, Sampedro-Nuñez, Miguel, Samaniego, M. Luz, Díaz-Muñoz, Marcos, Sánchez-Cenizo, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816757/ https://www.ncbi.nlm.nih.gov/pubmed/34668173 http://dx.doi.org/10.1007/s12020-021-02900-0

Ejemplares similares

SAT-LB078 Acromegaly Disease Activity According to ACRODAT® in Spain: ACROVAL Study
por: Marazuela, Monica, et al.
Publicado: (2019)

ACRODAT® and AcroVoice: an insight into a holistic approach to the management of acromegaly
por: Lundie, Mark, et al.
Publicado: (2019)

Factors associated with therapeutic response in acromegaly diagnosed in the elderly in Spain
por: Biagetti, Betina, et al.
Publicado: (2022)

Development of ACRODAT(®), a new software medical device to assess disease activity in patients with acromegaly
por: van der Lely, Aart J., et al.
Publicado: (2017)

Preference of acromegaly patients for treatment attributes in Spain
por: Fajardo, Carmen, et al.
Publicado: (2023)

Diagnosis, treatment and follow-up of patients with acromegaly in a clinical practice setting in Spain: the ACROPRAXIS program Delphi survey
por: de Pablos-Velasco, Pedro, et al.
Publicado: (2019)

Burden of diabetes mellitus in patients with acromegaly treated with second-line pharmacotherapy in Spain
por: Sánchez-Cenizo, Laura, et al.
Publicado: (2019)

Revisiting the usefulness of the short acute octreotide test to predict treatment outcomes in acromegaly
por: Marques-Pamies, Montserrat, et al.
Publicado: (2023)

Prevalence of acromegaly in patients with symptoms of sleep apnea
por: Sesmilo, Gemma, et al.
Publicado: (2017)

Data mining analyses for precision medicine in acromegaly: a proof of concept
por: Gil, Joan, et al.
Publicado: (2022)

Pasireotide in the Personalized Treatment of Acromegaly
por: Puig-Domingo, Manel, et al.
Publicado: (2021)

Bringing Cardiovascular Comorbidities in Acromegaly to an Update. How Should We Diagnose and Manage Them?
por: Ramos-Leví, Ana M., et al.
Publicado: (2019)

Mortality risk in adults according to categories of impaired glucose metabolism after 18 years of follow-up in the North of Spain: The Asturias Study
por: Ares, Jessica, et al.
Publicado: (2019)

Effectiveness of lanreotide autogel 120 mg at extended dosing intervals for acromegaly
por: Bernabéu, Ignacio, et al.
Publicado: (2020)

Correction: Mortality risk in adults according to categories of impaired glucose metabolism after 18 years of follow-up in the North of Spain: The Asturias Study
por: Ares, Jessica, et al.
Publicado: (2019)

MON-317 Prognostic Factors and Mortality According to the Structural and Functional Classification of Acromegaly
por: Haro, Andrea Rocha, et al.
Publicado: (2020)

Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response
por: Gil, Joan, et al.
Publicado: (2022)

Hypophysitis following Treatment with Ustekinumab: Radiological and Pathological Findings
por: Ramos-Leví, Ana M., et al.
Publicado: (2018)

MON-560 Thyroid Cancer and Iodine Nutritional Status in Asturias (Spain)
por: Riestra, María, et al.
Publicado: (2019)

Reclassification of type 2 diabetes to type 1 diabetes in Asturias (Spain) between 2011 and 2020
por: Rodríguez Escobedo, Raúl, et al.
Publicado: (2023)

Acromegaly: Role of Surgery in the Therapeutic Armamentarium
por: Guinto, Gerardo, et al.
Publicado: (2012)

Sex-related disparities in the incidence and outcomes of infective endocarditis according to type 2 diabetes mellitus status in Spain, 2016–2020
por: Lopez-de-Andres, Ana, et al.
Publicado: (2022)

Impact of COVID-19 Lockdown on Glycemic Control in Adults with Type 1 Diabetes Mellitus
por: Pla, Begoña, et al.
Publicado: (2020)

COVID-19 Lockdown and Changes of the Dietary Pattern and Physical Activity Habits in a Cohort of Patients with Type 2 Diabetes Mellitus
por: Ruiz-Roso, María Belén, et al.
Publicado: (2020)

Acromegaly
por: Chanson, Philippe, et al.
Publicado: (2008)

Acromegaly
Publicado: (1932)

Acromegaly
por: Gibson, G. A.
Publicado: (1899)

Acromegaly
Publicado: (1890)

An Efficient COVID-19 Prediction Model Validated with the Cases of China, Italy and Spain: Total or Partial Lockdowns?
por: Sanchez-Caballero, Samuel, et al.
Publicado: (2020)

Sleep Apnea in Patients with Acromegaly. Frequency, Characterization and Positive Pressure Titration
por: Hernández-Gordillo, Daniel, et al.
Publicado: (2012)

Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly
por: Chenlo, Miguel, et al.
Publicado: (2019)

Evolution of the lethality due to SARS-CoV-2 in Spain according to age group and sex
por: Saavedra, Pedro, et al.
Publicado: (2022)

Management of acromegaly
por: Vasilev, Vladimir, et al.
Publicado: (2010)

Localized acromegaly
por: Palikhe, Gaurav, et al.
Publicado: (2012)

Acromegaly in pregnancy
por: Koshy, T. George, et al.
Publicado: (2012)

Essays on Acromegaly
Publicado: (1892)

The Endothelium in Acromegaly
por: Maffei, Pietro, et al.
Publicado: (2019)

Pregnancy and acromegaly
por: Muhammad, Ammar, et al.
Publicado: (2016)

The acromegaly lipodystrophy
por: Freda, Pamela U.
Publicado: (2022)

Acromegaly and Vaccination
por: Leverson, M. R.
Publicado: (1899)

Cannot write session to /tmp/vufind_sessions/sess_7mpftum5hq92h6m611pjpcvh80